Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / SHS USD
-
Total 13F shares
-
55,363,658
-
Share change
-
-179,225
-
Total reported value
-
$7,167,098,171
-
Put/Call ratio
-
54%
-
Price per share
-
$129.44
-
Number of holders
-
473
-
Value change
-
-$19,666,748
-
Number of buys
-
210
-
Number of sells
-
215
Institutional Holders of Jazz Pharmaceuticals plc - SHS USD (JAZZ) as of Q3 2023
As of 30 Sep 2023 Jazz Pharmaceuticals plc - SHS USD (JAZZ) had 473 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 55,363,658 shares of stock of the company.
Largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, LSV ASSET MANAGEMENT, STATE STREET CORP, WELLINGTON MANAGEMENT GROUP LLP, JPMORGAN CHASE & CO, SAMLYN CAPITAL, LLC, FMR LLC, RENAISSANCE TECHNOLOGIES LLC, and AMERIPRISE FINANCIAL INC.
This table shows 482 institutional shareholders of the security as of 30 Sep 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.